Cell-Free DNA (cfDNA): Market Size and Share Analysis

• Executive Summary
  • Introduction
  • Molecular Diagnostic Technologies
  • Molecular Diagnostics in Healthcare
  • Global Molecular Diagnostics Market
    • Table Global Molecular Diagnostics Market (2016-2021) –Infectious Disease, Blood Screening, Histology, Cancer Assays, Transplant, Inherited Diseases ($ millions)
    • Table Global Molecular Diagnostics Market (2016) –Infectious Disease, Blood Screening, Histology, Cancer Assays, Transplant, Inherited Diseases ($ millions)
    • Table Global Molecular Diagnostics Market (2016-2021) –Infectious Disease, Blood Screening, Histology, Cancer Assays, Transplant, Inherited Diseases ($ millions)
    • Table Global Molecular Diagnostics Market (2016-2021) –United States, Europe, Japan, China, Latin America, Rest of World ($ millions)
    • Table Global Molecular Diagnostics Market (2016) –United States, Europe, Japan, China, Latin America, Rest of World ($ millions)
    • Table Global Molecular Diagnostics Market (2016-2021) –United States, Europe, Japan, China, Latin America, Rest of World ($ millions)
  • Major Conclusions
• Introduction to Clinical Molecular Diagnostics
  • Introduction
  • Nucleic Acid Amplification Test (NAAT) Technologies
    • Real-Time PCR (qPCR)
    • Isothermal Amplification
      • Table Selected Isothermal Amplification Methods and Platform Examples
    • Trends in Nucleic Acid Amplification Testing and Emerging Technologies
  • Microarrays
    • Table Selected Clinical Array Component and Microarray Systems
    • Trends in Microarray Testing
  • In Situ Hybridization (ISH)
    • Table Selected Commercial In Situ Hybridization (ISH) Tests
    • Trends in In Situ Hybridization Testing
  • Sequencing
    • Table Selected Clinical Next-Generation Sequencing Platforms
    • Trends in Clinical Sequencing
  • Conclusions
• Molecular Diagnostics in Healthcare
  • Introduction
  • Reimbursement Environment for Molecular Diagnostics
  • Molecular Diagnostics and the Clinical Utility Standard
  • Laboratory-Developed Tests Are Here to Stay
  • Conclusions
• Market for Molecular Infectious Disease Diagnostics
  • Table Market-Available Molecular Diagnostic Platforms - POC, Hospital and Developing World (Vendor, Assay Menu, Planned Assays, Regulatory Status, Procedure Integration, Test Principles)
  • Market Analysis
    • Table Global Molecular Infectious Disease Diagnostics Market (2016-2021) –Hepatitis, HIV, HAIs/Sepsis, CT/NG, HPV, Respiratory, Mycobacteria/TB, Other ($ millions)
    • Table Global Molecular Infectious Disease Diagnostics Market (2016) - Hepatitis, HIV, HAIs/Sepsis, CT/NG, HPV, Respiratory, Mycobacteria/TB, Other ($ millions)
    • Table Global Molecular Infectious Disease Diagnostics Market (2016-2021) –Hepatitis, HIV, HAIs/Sepsis, CT/NG, HPV, Respiratory, Mycobacteria/TB, Other ($ millions)
    • Table Global Molecular Infectious Disease Diagnostics Market (2016-2021) –United States, Europe, Japan, China, Latin America, Rest of World ($ millions)
    • Table Global Molecular Infectious Disease Diagnostics Market (2016) - United States, Europe, Japan, China, Latin America, Rest of World ($ millions)
    • Table Global Molecular Infectious Disease Diagnostics Market (2016-2021) –United States, Europe, Japan, China, Latin America, Rest of World ($ millions)
    • Table Global Molecular Infectious Disease Diagnostics Market Share - Abbott Diagnostics, BD, bioMérieux, Cepheid, Hologic, Qiagen, Roche Diagnostics, Siemens Healthcare Diagnostics, Others (%)
  • CT/NG, HPV and Women's Health
  • Hepatitis
  • HIV
  • Hospital-Acquired Infections (HAIs) and Sepsis
  • Respiratory
  • Tuberculosis
  • Conclusions
• Market for Molecular Blood Transfusion Diagnostics
  • Introduction
  • Market Analysis
    • Table Global NAT Blood Screening Market (2016-2021) –United States, Europe, Japan, China, Latin America, Rest of World ($ millions)
    • Table Global NAT Blood Screening Market (2016) - United States, Europe, Japan, China, Latin America, Rest of World ($ millions)
    • Table Global NAT Blood Screening Market (2016-2021) –United States, Europe, Japan, China, Latin America, Rest of World ($ millions)
    • Table Commonly Tested Pathogens in Blood Screening Pathogen
    • Table Global NAT Blood Screening Share - Grifols, Roche Diagnostics, Others (%)
  • New Infectious Disease Threats and Assay Introduction
  • Conclusions
• Market for Molecular Histology and Cytology Diagnostics
  • Introduction
  • Market Analysis
    • Table Global Molecular Histology Diagnostics Market (ISH, Other Direct Hybridization) by Application (2016-2021) –Genetic Disorders, Cancer, Other/Infectious ($ millions)
    • Table Global Molecular Histology Diagnostics Market (ISH, Other Direct Hybridization) by Application (2016) - Genetic Disorders, Cancer, Other/Infectious ($ millions)
    • Table Global Molecular Histology Diagnostics Market (ISH, Other Direct Hybridization) by Application (2016-2021) –Genetic Disorders, Cancer, Other/Infectious ($ millions)
    • Table Global Molecular Histology Diagnostics Market (2016-2021) - United States, Europe, Japan, China, Latin America, Rest of World ($ millions)
    • Table Global Molecular Histology Diagnostics Market (2016) - United States, Europe, Japan, China, Latin America, Rest of World ($ millions)
    • Table Global Molecular Histology Diagnostics Market (2016-2021) –United States, Europe, Japan, China, Latin America, Rest of World ($ millions)
  • RNA in Molecular Histology
  • CISH and Other Reagent Chemistries
  • Prenatal Testing moves to NIPT
  • Conclusions
• Market for Molecular Cancer Diagnostics
  • Introduction
  • Bringing Molecular Resolution to Cancer Diagnostics
  • Tissue-Based Diagnostics, Companion Assays and the Status Quo in IVD
    • Table Major Molecular Companion and Complementary Assays for Cancer Test or Analyte / Primary Application / Sample Product Examples
  • Market Analysis
    • Table Global Molecular Cancer Diagnostics Market (2016-2021) –United States, Europe, Japan, China, Latin America, Rest of World ($ millions)
    • Table Global Molecular Cancer Diagnostics Market (2016) –United States, Europe, Japan, China, Latin America, Rest of World ($ millions)
    • Table Global Molecular Cancer Diagnostics Market (2016-2021) –United States, Europe, Japan, China, Latin America, Rest of World ($ millions)
    • Table Global Molecular Cancer Diagnostics Market Share - Roche Diagnostics, Illumina, Qiagen, Others (%)
  • U.S. Market
  • EU Market
  • Chinese Market
  • Rest of the World
  • Conclusions
• Market for Molecular Transplant Diagnostics
  • Introduction
  • Market Analysis
    • Table Global Molecular Transplant Diagnostics Market (2016-2021) –United States, Europe, Japan, Rest of World ($ millions)
    • Table Global Molecular Transplant Diagnostics Market (2016) –United States, Europe, Japan, Rest of World ($ millions)
    • Table Global Molecular Transplant Diagnostics Market (2016-2021) –United States, Europe, Japan, Rest of World ($ millions)
    • Table Global Molecular Transplant Diagnostics Market Share - Thermo Fisher Scientific, Immucor, CareDx, Others (%)
  • Technological Shift to Next-Generation Sequencing and Real-Time PCR
  • Conclusions
• Market for Molecular Diagnostics in Inherited Diseases
  • Market Analysis
    • Table Global Molecular Diagnostics Market in Inherited Diseases (2016-2021) - United States, Europe, Rest of World ($ millions)
    • Table Global Molecular Diagnostics Market in Inherited Diseases (2016) –United States, Europe, Rest of World ($ millions)
    • Table Global Molecular Diagnostics Market in Inherited Diseases (2016-2021) –United States, Europe, Rest of World ($ millions)
  • Thrombophilia and Coagulation Markers
  • Autism
  • Alzheimer's Disease
  • Cardiovascular Disease
  • Diabetes
  • Psychiatric Disorders
  • Gastrointestinal Conditions
  • Other Autoimmune Diseases
  • Conclusions
• Molecular Diagnostics Market Summary and Major Conclusions
  • Market Summary
    • Table Global Molecular Diagnostics Market (2016-2021) –Infectious Disease, Blood Screening, Histology, Cancer Assays, Transplant, Inherited Diseases ($ millions)
    • Table Global Molecular Diagnostics Market (2016) –Infectious Disease, Blood Screening, Histology, Cancer Assays, Transplant, Inherited Diseases ($ millions)
    • Table Global Molecular Diagnostics Market (2016-2021) –Infectious Disease, Blood Screening, Histology, Cancer Assays, Transplant, Inherited Diseases ($ millions)
    • Table Global Molecular Diagnostics Market (2016-2021) –United States, Europe, Japan, China, Latin America, Rest of World ($ millions)
    • Table Global Molecular Diagnostics Market (2016) –United States, Europe, Japan, China, Latin America, Rest of World ($ millions)
    • Table Global Molecular Diagnostics Market (2016-2021) –United States, Europe, Japan, China, Latin America, Rest of World ($ millions)
  • Major Conclusions
• Company Profiles
  • Abbott Diagnostics
    • Table Abbott Diagnostics Revenue (2013-2016) ($ millions)
    • Infectious Diseases/qPCR
    • Cytogenetics/Oncology/FISH
    • Molecular ID/AST
  • Advanced Cell Diagnostics
  • Affymetrix (Thermo Fisher Scientific)
    • Table Affymetrix Revenue (2013-2016) ($ millions)
  • Agilent Technologies
    • Table Agilent Technologies Revenue (FY 2013-FY 2016) ($ millions)
  • Alere
    • Table Alere Revenue (2013- 2016) ($ millions)
  • Amoy Diagnostics
  • Applied Spectral Imaging
  • Beckman Coulter (Danaher)
  • Becton, Dickinson & Co. (BD)
    • Table Becton, Dickinson & Co. (BD) Revenue (FY 2013-FY 2016) ($ millions)
    • Molecular
    • Histology/Cytology
    • Flow Cytometry
  • Beijing Genomics Institute (BGI)
  • Berry Genomics
  • Biocartis
    • Table Biocartis Revenue (2013-2016) ($ millions)
  • bioMérieux
    • Table bioMérieux Revenue (2013-2016) ($ millions)
    • Molecular
    • Sequencing
  • Bio-Rad Laboratories
    • Transplant Diagnostics
    • Molecular Diagnostic QC Products
    • Sequencing
  • BioView
    • Table BioView Revenue (2013-2016) ($ millions)
  • CareDx
    • Sequencing
    • Molecular HLA Typing
  • Cepheid (Danaher)
    • Table Cepheid Revenue (2013-2016) ($ millions)
    • Molecular Hospital-Acquired Infection (HAI) Testing
    • Molecular Sexual Health and Women's Health Testing
    • Molecular Critical Infectious Disease Testing
    • Molecular Oncology Testing
  • Covaris
  • Dako (Agilent Technologies)
    • Table Dako Revenue (2013-2016) ($ millions)
  • Eiken Chemical
    • Table Eiken Chemical Revenue (FY 2013-FY 2016) ($ millions)
  • Epigenomics
    • Table Epigenomics Revenue (2013-2016) ($ millions)
  • Exosome Diagnostics
  • GenMark Diagnostics
    • Table GenMark Diagnostics Revenue (2013-2016) ($ millions)
  • Grifols
    • Table Grifols Diagnostic Revenue (2013-2016) ($ millions)
    • Molecular Immunohematology and Specialty Testing Services
    • NAT Blood Screening
  • Hologic
    • Table Hologic Revenue (FY 2013-FY 2016) ($ millions)
    • Molecular Cytology / Histology (HPV)
    • Other Molecular (STIs, HIV, HCV, TB, Respiratory)
    • Microbiology (AccuProbe Molecular Culture ID Tests)
  • Illumina
    • Table Illumina Revenue (2013-2016) ($ millions)
    • Sequencing
    • Translational Research
    • Clinical Assay Development
    • Industry Lab-Developed Tests
    • Arrays
  • Immucor
    • Table Immucor Revenue (FY 2013-FY 2016) ($ millions)
    • Transfusion Diagnostics
    • Transplant Diagnostics
    • Immucor Dx Laboratory Service
  • Janssen Diagnostics (Johnson & Johnson)
  • Leica Biosystems (Danaher)
    • Table Leica Biosystems Revenue (2013-2016) ($ millions)
  • Luminex Corporation
    • Table Luminex Corporation Revenue (2013- 2016) ($ millions)
    • Business Expansion
    • MAGPIX Multiplexing
    • ARIES Molecular System
  • Meridian Bioscience
    • Table Meridian Bioscience Revenue (FY 2013-FY 2016) ($ millions)
  • Nanosphere (Luminex)
    • Table Nanosphere Revenue (2013-2016) ($ millions)
  • NanoString Technologies
    • Table NanoString Technologies Revenue (2013-2016) ($ millions)
    • Clinical Diagnostics
    • Companion Assay Development
    • Research Platforms
    • Sequencing
  • Qiagen
    • Table Qiagen Revenue (2013-2016) ($ millions)
    • Molecular Infectious Disease
    • Cancer Diagnostics
    • Transplant Diagnostics
    • Next-Generation Sequencing
    • Circulating Tumor Cells
  • Quidel
    • Table Quidel Revenue (2013-2016) ($ millions)
  • Roche Diagnostics
    • Table Roche Diagnostics Revenue (2013-2016) ($ millions)
    • Molecular Diagnostics
    • Blood Screening
    • Sequencing
    • Liquid Biopsy
    • Microbiology
  • Siemens Healthcare Diagnostics
  • Thermo Fisher Scientific
    • Table Thermo Fisher Scientific Revenue (2013-2016) ($ millions)
    • Transplant Diagnostics
    • qPCR
    • Sequencing
  • Vela Diagnostics
  • Ventana Medical Systems (Roche)
    • Table Ventana Medical Systems Revenue (2013-2016) ($ millions)

Cell-Free DNA (cfDNA) Markets: Consumables, Systems/Hardware, Services

Cell-Free DNA (cfDNA) Markets: Consumables, Systems/Hardware, Services examines the opportunity for cell-free DNA analysis instruments, consumables, kits, and related software. Current sales analysis and projections to 2021 are provided, as well as measurements of market growth; sales by product type; sales revenues of major competitors in the market; and geographic performance in North America, Europe, Asia-Pacific, and the rest of the world. Intellectual Property Litigation in the cfDNA analysis market is discussed, as well as collaborations. Illumina and Thermo Fisher Scientific are among the manufacturers discussed in the report’s competitor analysis. Market challenges and responses to these challenges are also presented